SELECTED PUBLICATIONS
About Us Research Publications Contact
Us
Tatapudy, S., Bruening, S., Gleason, G., and Toth, M. "Validation and use of a computer-assisted counting procedure to quantify BrdU-labeled proliferating cells in the early postnatal mouse hippocampus." J Neurosci Methods. 2008 Jul 30;172(2):173-7. Epub 2008 Apr 25.
Zupan B, Toth M. “Wild type male offspring of fmr-1+/- mothers exhibit characteristics of the fragile x phenotype.” Neuropsychopharmacology. 2008 Jan 2 [Epub ahead of print].
Toth, M. Zupan, B. “Neurobiology of anxiety disorders.” The Handbook of Contemporary Neuropharmacology. 2007, John Wiley and Sons Inc.
Toth M. “Use of mice with targeted genetic inactivation in the serotonergic system for the study of anxiety. "Serotonin Receptors in Neurobiology" New Frontiers in Neuroscience series, CRC Press, May 18, 2007.
Bortolozzi, A, Díaz-Mataix, L, Toth, M, Celada, P, Artigas, F. “In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain.” Psychopharmacology (Berl). 2007 Apr;191(3):745-58. Epub 2007 Jan 30.
Guiard BP, Guilloux J-P, Reperant C, Toth M, Gardier AM. “Substance p neurokinin 1 receptor activation within the dorsal raphe nucleus controls serotonin release in the mouse frontal cortex.” Mol. Pharmacol. 2007 Dec;72(6):1411-8. Epub 2007 Sep 21.
Guilloux, J.P., David, D.J., Guiard, B.P., Chenu, F., Repérant, C., Toth, M., Bourin, M., Gardier, A.M. Blockade of 5-HT1A receptors by (+/-)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout mice. Neurophsychopharmacology, 2006 Oct;31(10):2162-72. Epub 2006 Jan 25.
Weisstaub NV, Zhou M, Lira A, Lambe E, González-Maeso J, Hornung JP, Sibille E, Underwood M, Itohara S, Dauer WT, Ansorge MS, Morelli E, Mann JJ, Toth M, Aghajanian G, Sealfon SC, Hen R, Gingrich JA. Cortical 5-HT2A Receptor Signaling Modulates Anxiety-Like Behaviors in Mice. Science, 313(5786):536-40, 2006.
Kushnir-Sukhov NM, Gilfillan AM, Coleman JW, Brown JM, Bruening S, Toth M, and Metcalfe DD. 5-hydroxytryptamine induces mast cell adhesion and migration. J. Immunology, 177:6422-6432, 2006.
Yun SW, Platholi J, Flaherty MS, Fu W, Kottmann AH, Toth M. Fmrp is required for the establishment of the startle response during the critical period of auditory development. Brain Res. 2006 Sep 19;1110(1):159-65. Epub 2006 Aug 2.
Bruening, S., Oh, E., Hetzenauer, F., Escobar-Alvarez, S., Westphalen, R.I., Hemmings, H.C. Jr., Singewald, N., Shippenberg, T., Toth, M. The anxiety-like phenotype of 5-HT receptor null mice is associated with genetic background-specific perturbations in the prefrontal cortex GABA-glutamate system. J Neurochem. 99(3):892-899, 2006 .
Chen ZY, Jing D, Bath KG, Ieraci A, Khan T, Siao CJ,. Herrera DG, Toth M, Yang C, McEwen BS, Hempstead BL, Lee FS. Genetic Variant BDNF (Val66Met) Polymorphism Alters Anxiety-related Behavior. Science, 314:140-3, 2006.
Van Bogaert M, Oosting R, Toth M, Groenink L, van Oorschot R, Olivier B. Effects of genetic background and null mutation of 5-HT(1A) receptors on basal and stress-induced body temperature: Modulation by serotonergic and GABA(A)-ergic drugs. Eur J Pharmacol. 2006 Nov 21;550(1-3):84-90. Epub 2006 Sep 8.
Díaz-Mataix L, Scorza MC, Bortolozzi A, Toth M, Celada P, Artigas F. Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action. J. Neurosci. 2005 Nov 23;25(47):10831-43.